WebJun 12, 2024 · In October 2015, Double Bond Pharmaceutical acquired the rights to Temodex - a drug registered in Belarus for the treatment of brain tumors. In July 2016, the company was granted Orphan Drug Designation status by EMA for Temodex. (C) 2024 Electronic News Publishing, source ENP Newswire. All news about DOUE BOND: WebDouble Bond Pharmaceutical International AB is a pharmaceutical company which develops and commercializes approaches for treatment of cancers, infections, autoimmune diseases and other life ...
Double Bond Pharmaceutical International AB LinkedIn
WebMember at food Quality student association (FQSA) academic chapter. leader of the winner in marketing contest during summer internship with Double Bond pharmaceutical company. Trained in Egyskan lab making analysis … WebDisclosed are compounds of the formula I, or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein A is a bond, -C(O)-, or-C(R3')(R4')-; X is -N(R1)- or -C(R6)(R7)-; Y is -S(O)2-, -C(=O)-, -PO(OR9) or -C(R6'R7')-; is a single or double bond and R, R1, R2, R3, R4, R3', R4', R5, R6, R6', R7 and R7' are as defined in the … bitmap image in photoshop
DBBPF Stock News DOUBLE BOND PHARMACEUTICAL …
WebNov 4, 2024 · About Double Bond Pharmaceutical AB (DBP): DBP is a Swedish pharmaceutical company founded in 2014 with the aim of developing and commercializing innovative products and methods for the treatment ... WebAt Double Bond Pharmaceutical, our areas of expertise are brain cancer, liver cancer and pneumonia. We have developed ways to treat these diseases much more effectively with … Our Products Our specialties are brain cancer, liver cancer, and pneumonia. … Our News Find out more about us in our news categories Press Releases, … Drugsson Drugsson is our own drug distribution company with its own … Post address: Virdings allé 32B, 75 450 Uppsala, Sweden Visiting address: … Pipeline In this section you will find current statistics on our products. Our drug for … Double Bond Pharmaceutical is a Swedish biotechnology company that specializes … Double Bond Pharmaceutical AB (DBP) has received Orphan Drug Designation from … The BeloGal® technology was developed by Double Bond Pharmaceutical and the … Press Releases All press releases about our company are published by … WebDouble Bond Pharmaceutical AB (”Double Bond”) has filed a PCT patent application to protect the use of ferrous succinate for certain indications. Last year, a clinical study was conducted with collaboration between Double Bond and Skellefteå University, showed that iron succinate significantly improves iron uptake, iron saturation and iron ... data factory arm テンプレート